# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stephens & Co. analyst Scott Fidel reiterates Encompass Health (NYSE:EHC) with a Overweight and maintains $94 price target.
RBC Capital analyst Ben Hendrix maintains Encompass Health (NYSE:EHC) with a Outperform and raises the price target from $83...
Raymond James analyst John Ransom reiterates Encompass Health (NYSE:EHC) with a Strong Buy and raises the price target from ...